文献速递主动脉疾病

急性B型主动脉夹层高危特征及修复时机的影响

Impact of high-risk features and timing of repair for acute type B aortic dissections.
PubMed 文献 · J Vasc Surg · 2022-03-29

基于血管质量倡议(Vascular Quality Initiative)数据库2014至2020年因急性及亚急性B型主动脉夹层(TBAD)伴高危特征(HRF)行胸主动脉腔内修复(TEVAR)的1100例患者,分析修复时机与HRF数量对结局的影响。结果显示15天及以上行TEVAR与更低的院内/30天死亡率独立相关(比值比0.38;P=0.0388)且1年生存改善,术后卒中与更早修复(0-2天)相关,HRF数量与主要或次要结局无显著差异。

要点

  • TBAD伴HRF患者TEVAR延迟至少15天与生存改善相关。
  • TEVAR延迟至少3天与卒中减少相关。
  • HRF数量超过一个与更差结局无统计学关联。

核心结论

  • TBAD伴HRF患者自症状出现至少延迟15天行TEVAR与生存改善相关,支持延迟至亚急性期的理论。
  • TEVAR延迟至少3天与卒中减少相关。
  • HRF数量超过一个与更差结局无统计学关联。
  • 作者认为,HRF分类较新且尚无修复指南,本研究强调早期干预HRF的风险,并提示这些患者似乎受益于TEVAR前至少短期的稳定期。

研究设计与样本

  • 回顾性查询血管质量倡议(Vascular Quality Initiative)数据库,纳入2014至2020年因急性及亚急性TBAD伴HRF行TEVAR的患者。
  • 排除破裂、灌注不良及无并发症患者;HRF按指南定义为难治性高血压、疼痛或快速扩张/动脉瘤大于40 mm。
  • 共纳入1100例患者,其中811例有1个HRF,249例有2个,40例有3个。
  • 按修复时机分组:0至2天309例,3至6天262例,7至14天270例,15天及以上259例。
  • 主要结局为院内/30天死亡率和1年生存,主要暴露变量为症状至修复天数和HRF数量;次要结局为脊髓缺血、卒中和逆行性A型夹层(RTAD)。

主要发现

  • 基于HRF数量的主要或次要结局均无显著差异。
  • 15天及以上行TEVAR与更低的院内/30天死亡率独立相关(比值比0.38;P=0.0388)且1年生存改善。
  • 术后卒中与更早修复(0-2天)相关。
  • 修复时机与脊髓缺血、逆行性A型夹层或再干预无关联。

关键数值与推荐

  • HRF按指南定义为难治性高血压、疼痛或快速扩张/动脉瘤大于40 mm。
  • 15天及以上行TEVAR与更低的院内/30天死亡率独立相关(比值比0.38;P=0.0388)。

临床怎么用

  • 作者认为,TBAD伴HRF患者似乎受益于TEVAR前至少短期的稳定期,并强调早期干预的风险。
  • 作者指出,TEVAR延迟至少15天与生存改善相关,延迟至少3天与卒中减少相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The new Society for Vascular Surgery/Society for Thoracic Surgery reporting standards for type B aortic dissection (TBAD) categorize clinical presentations of aortic dissection into uncomplicated, high-risk features (HRF), and complicated groups. Although it is accepted that complicated dissections require immediate repair, the optimal timing of repair for HRF has yet to be established. This study aims to identify the ideal timing of thoracic endovascular aortic repair (TEVAR) for HRF, as well as outcomes associated with specific HRF. METHODS: The Vascular Quality Initiative was queried for TEVARs performed for acute and subacute TBAD with HRF from 2014 to 2020. Rupture, malperfusion, and uncomplicated patients were excluded. HRF were defined per the guidelines as refractory hypertension, pain, or rapid expansion/aneurysm of more than 40 mm. The primary outcomes were in-hospital/30-day mortality and 1-year survival with primary exposure variables being days from symptoms to repair and number of HRFs. Secondary outcomes were spinal cord ischemia, stroke, and retrograde type A dissection (RTAD). RESULTS: Of the 1100 patients who met inclusion criteria, 811 had one HRF, 249 had two, and 40 had three. There were no significant differences in primary or secondary outcomes based on number of HRFs. There were 309 patients who underwent repair at 0 to 2 days, 262 at 3 to 6 days, 270 at 7 to 14 days, and 259 at 15 days or more. TEVAR performed at 15 days or more was independently associated with lower in-hospital/30-day mortality (odds ratio, 0.38; P = .0388) and improved 1-year survival. Postoperative stroke was associated with earlier repair (0-2 days). There was no association of timing of repair with spinal cord ischemia, retrograde type A dissection or reintervention. CONCLUSIONS: TEVAR for TBAD with HRF delayed at least 15 days from symptom onset is associated with improved survival, supporting the theory that it is best to delay TEVAR until the subacute phase. Additionally, TEVAR delayed at least 3 days is associated with a decrease in stroke. Having more than one HRF was not associated statistically with worse outcomes. Because the classification of HRF is relatively new and without guidelines for repair, this study highlights the risks of early intervention for HRF and suggests that these patients seem to benefit from at least a short stabilization period before TEVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Potter HA, Ding L, Han SM, et al. Impact of high-risk features and timing of repair for acute type B aortic dissections. J Vasc Surg. 2022. PMID: 35364121. doi:10.1016/j.jvs.2022.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。